medondo holding AG · ISIN: DE0008131350 · Directors Dealings
Insider Transaction Snapshot

medondo holding AG

Directors Dealings: 15th November 2024
Reporting obligation triggered by: Rotter, Dr. Jürgen
Trading volume: 5.000,00 EUR
Type: Buy

The Insider Transaction was made by Rotter, Dr. Jürgen . The transaction toke place on 15th July 2024. The aggregated volume was 5.000,00 EUR, based on an average price of 1,00 EUR. The nature of the Investment was Buy.

Short Selling Radar - Net Short Selling Positions

EQS-Newswire - Latest Company News, Ad-hoc News, Research

Directors Dealings

Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.

Reset filter
New DD.i/o
08 December 2022
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 7th December 2022. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 7th December 2022,

The Insider Transaction was made by Powell, Rice . The transaction toke place on 2nd December 2022. The order was executed at the trading place NYSE. . The aggregated volume was 106.811,08 USD, based on an average price of 16,26 USD. The nature of the Investment was Buy.

Fresenius Medical Care AG & Co. KGaA
27 May 2022
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 27th May 2022. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 27th May 2022,

The Insider Transaction was made by Powell, Rice . The transaction toke place on 24th May 2022. The order was executed at the trading place XETRA. . The aggregated volume was 2.792.923,58 EUR, based on an average price of 56,00 EUR. The nature of the Investment was not specified.

Fresenius Medical Care AG & Co. KGaA
27 May 2022
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 27th May 2022. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 27th May 2022,

The Insider Transaction was made by Powell, Rice . The transaction toke place on 24th May 2022. . The aggregated volume was 1.391.093,80 EUR, based on an average price of 56,02 EUR. The nature of the Investment was not specified.

Fresenius Medical Care AG & Co. KGaA
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

Important note:
The information presented here is usually updated once a day. Insofar as you include insider information/director dealings in your daily investment decisions and time-critical parameters play a role in the implementation of your trading strategy, you can obtain this information via a corresponding query at the BaFin or by monitoring the EQS-News intraday publications. 


Further information on the topic can be found on the following pages:

https://www.bafin.de/EN/Aufsicht/BoersenMaerkte/Transparenz/InformationspflichtenEmittenten/DirectorsDealings/directorsdealings_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2016/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/Aufsicht/BoersenMaerkte/Marktmissbrauch/Insiderueberwachung/insiderueberwachung_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2017/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/PublikationenDaten/Datenbanken/DirectorsDealings/directorsdealings_node.html